Primary Analysis and Prioritization of Risks of Biowaiver Procedure

ScienceRise: Pharmaceutical Science
doi 10.15587/2519-4852.2016.76466
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Private Company Technology Center

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy